Cantitate/Preț
Produs
Total produse
Vezi coșul
GABA and Sleep: Molecular, Functional and Clinical Aspects de Jaime M. Monti

GABA and Sleep: Molecular, Functional and Clinical Aspects

Editat de Jaime M. Monti, Seithikurippu Ratnas Pandi-Perumal, Hanns Möhler
en Limba Engleză Hardback – 29 sep 2010
GABA (gamma-aminobutyric acid) is the main neurotransmitter regulating sleep. The majority of drugs presently in use for the treatment of sleep disorders act by enhancing GABAergic neuronal inhibition. The GABA system is, therefore, of prime clinical relevance for the therapy of insomnia.
The focus of this volume is on the neuropsychopharmacology and the clinical impact of the GABA system in regulating sleep and wakefulness. It presents molecular, neuropharmacological, systems-biological and clinical approaches to the understanding of the mechanism of action of GABA and GABAergic drugs. It also explores the role of GABA in the basic drives that affect sleep, and the influences that adapt sleep and wakefulness to external events.
 
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 139293 lei  43-57 zile
  Springer – 22 sep 2014 139293 lei  43-57 zile
Hardback (1) 139775 lei  43-57 zile
  Springer – 29 sep 2010 139775 lei  43-57 zile

Preț: 139775 lei

Preț vechi: 147131 lei
-5% Nou

Puncte Express: 2097
Preț estimativ în valută:
26750€ • 27786$ • 22220£

Carte tipărită la comandă

Livrare economică 03-17 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783034602259
ISBN-10: 3034602251
Pagini: 480
Ilustrații: XXIV, 486 p.
Dimensiuni: 155 x 235 x 37 mm
Greutate: 0.84 kg
Ediția:2010
Editura: Springer
Colecția Springer
Locul publicării:Basel, Switzerland

Public țintă

Research

Descriere

GABA (gamma-aminobutyric acid) is the main neurotransmitter regulating sleep. The majority of drugs presently in use for the treatment of sleep disorders act by enhancing GABAergic neuronal inhibition. The GABA system is, therefore, of prime clinical relevance for the therapy of insomnia.
The focus of this volume is on the neuropsychopharmacology and the clinical impact of the GABA system in regulating sleep and wakefulness. It presents molecular, neuropharmacological, systems-biological and clinical approaches to the understanding of the mechanism of action of GABA and GABAergic drugs. It also explores the role of GABA in the basic drives that affect sleep, and the influences that adapt sleep and wakefulness to external events.
 

Cuprins

Section I – Basic Physiology and Pharmacology.- The New Pharmacology and Physiology of the GABA System: Function of GABAA and GABAB Receptor Subtypes.- Development of Subtype Selective GABAA Receptor Compounds for the Treatment of Anxiety Disorders, Primary and Comorbid Insomnia, and Epilepsy.- Distribution of GABAA Receptor Subunits in the Human Brain.- Pharmacokinetic Determinants of the Clinical Effects of Benzodiazepine Agonist Hypnotics.- Section II. Sleep Science and Circuitry.- Sleep and its Modulation by Drugs that Affect GABAA Receptor Function.- Subcortical Neuromodulation of Feedforward and Feedback Inhibitory Microcircuits by the Reticular Activating System.- Function of GABAB and GABAC Receptors in the Regulation of Basic and Higher Integrated Sleep-Waking Processes.- Interaction between GABAergic and Serotonergic Processes in the Dorsal Raphe Nucleus in the Control of REM Sleep and Wakefulness.- GABAergic Modulation of Pontine Cholinergic and Noradrenergic Neurons of Rapid Eye Movement (REM) Sleep Generation.- Involvement of GABAergic Mechanisms in the Laterodorsal and Pedunculopontine and Tegmental Nuclei (LDT-PPT) in the Promotion of REM Sleep.- GABAergic Mechanisms in the Ventral Oral Pontine Tegmentum – the REM Sleep Induction Site – in the Modulation of Sleep/Wake States.- The Role of GABAergic Modulation of Mesopontine Cholinergic Neurotransmission in Rapid Eye Movement (REM) Sleep.- Melatonin and Sleep: Possible Involvement of GABAergic Mechanisms.- GABA Involvement in the Circadian Regulation of Sleep.- Section – III. Neurotherapeutics.- Pathophysiology of Sleep Disorders.- Insomnia: Differential Diagnosis and Current Treatment Approach.- Zolpidem in the Treatment of Adult and Elderly Primary Insomnia Patients.- Efficacy and Safety of Zopiclone and Eszopiclone in the Treatment of Primary and Comorbid Insomnia.- Indiplon.- Polysomnographic and Clinical Assessment of Zaleplon for the Treatment of Primary Insomnia

Textul de pe ultima copertă

GABA (gamma-aminobutyric acid) is the main neurotransmitter regulating sleep.The majority of drugs presently in use for the treatment of sleep disorders actby enhancing GABAergic neuronal inhibition. This book brings together many of the world’s leading investigators to discuss current and anticipated developments in the areas of geriatric sleep medicine and provides a comprehensive examination of current principles and practice in this field. It is divided into three main sections: Section I:Basic Physiology and PharmacologySection II:Sleep Science and CircuitrySection III:NeurotherapeuticsThe areas covered include findings from research investigations various aspects of GABAergic systems and the regulation of sleep. The book is suitable for basic and clinical neuropharmacologists, sleep researchers, psychiatrists, sleep disorders specialists, clinicians, medical students, and all professionals interested in the interdisciplinary areas of sleep and neuropharmacology.

Caracteristici

Focuses on the neuropsychopharmacology of GABA and its role in sleep and wakefulness
Presents neurochemical, electrophysiological, and neuropharmacological approaches to understand GABAergic mechanisms
Offers an overview of current approaches and medications
Features contributing authors who are leading experts in the field of sleep and neuropharmacology
Includes supplementary material: sn.pub/extras